Facebook’s CFO David Wehner has joined his first board outside of the social media platform. Wehner has joined the board of a biotech company called Alector that is pursuing a novel approach to treating Alzheimer’s Disease. The South San Francisco-based company, founded in 2013, has also recruited two other board members; the former CFO of … Continue reading “Facebook’s CFO Is Trying to Cure Alzheimer’s Disease by Doing This”
